191 related articles for article (PubMed ID: 34199421)
1. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis.
Moriya K; Nishimura N; Namisaki T; Takaya H; Sawada Y; Kawaratani H; Kaji K; Shimozato N; Sato S; Furukawa M; Douhara A; Akahane T; Mitoro A; Yamao J; Yoshiji H
J Clin Med; 2021 Jun; 10(11):. PubMed ID: 34199421
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
[TBL] [Abstract][Full Text] [Related]
4. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.
Kasahara A; Hayashi N; Mochizuki K; Oshita M; Katayama K; Kato M; Masuzawa M; Yoshihara H; Naito M; Miyamoto T; Inoue A; Asai A; Hijioka T; Fusamoto H; Kamada T
J Hepatol; 1997 Mar; 26(3):574-83. PubMed ID: 9075665
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
[TBL] [Abstract][Full Text] [Related]
7. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
8. Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients.
Badra G; Lotfy M; El-Refaie A; Obada M; Abdelmonem E; Kandeel S; Fathy A
Acta Microbiol Immunol Hung; 2010 Mar; 57(1):29-42. PubMed ID: 20350877
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
Lebensztejn DM; Skiba E; Sobaniec-Łotowska ME; Kaczmarski M
Adv Med Sci; 2007; 52():114-9. PubMed ID: 18217401
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effects of qianggan capsule on the liver tissue pathology and PDGF-BB, TGF-beta1, TIMP-1, and MMP-1 factors in patients with chronic hepatitis B].
Wang H; Yang LM; Huang L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Oct; 31(10):1337-40. PubMed ID: 22097200
[TBL] [Abstract][Full Text] [Related]
11. Significance of serum matrix metalloproteinases and their inhibitors on the antifibrogenetic effect of interferon-alfa in chronic hepatitis C patients.
Ninomiya T; Yoon S; Nagano H; Kumon Y; Seo Y; Kasuga M; Yano Y; Nakaji M; Hayashi Y
Intervirology; 2001; 44(4):227-31. PubMed ID: 11509885
[TBL] [Abstract][Full Text] [Related]
12. TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma.
Ulrich D; Noah EM; von Heimburg D; Pallua N
Plast Reconstr Surg; 2003 Apr; 111(4):1423-31. PubMed ID: 12618601
[TBL] [Abstract][Full Text] [Related]
13. Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease Inhibitors.
Latronico T; Mascia C; Pati I; Zuccala P; Mengoni F; Marocco R; Tieghi T; Belvisi V; Lichtner M; Vullo V; Mastroianni CM; Liuzzi GM
Int J Mol Sci; 2016 Mar; 17(4):455. PubMed ID: 27023536
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2 and -9 and their inhibitors in peripheral blood cells of patients with chronic hepatitis C.
Lichtinghagen R; Huegel O; Seifert T; Haberkorn CI; Michels D; Flemming P; Bahr M; Boeker KH
Clin Chem; 2000 Feb; 46(2):183-92. PubMed ID: 10657374
[TBL] [Abstract][Full Text] [Related]
15. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.
Arthur MJ
Am J Physiol Gastrointest Liver Physiol; 2000 Aug; 279(2):G245-9. PubMed ID: 10915630
[TBL] [Abstract][Full Text] [Related]
16. The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity.
Toubi E; Kessel A; Grushko G; Sabo E; Rozenbaum M; Rosner I
Clin Exp Rheumatol; 2002; 20(2):221-4. PubMed ID: 12051403
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1.
Medeiros T; Saraiva GN; Moraes LA; Gomes AC; Lacerda GS; Leite PE; Esberard EB; Andrade TG; Xavier AR; Quírico-Santos T; Rosário NF; Silva AA
Dig Liver Dis; 2020 Oct; 52(10):1170-1177. PubMed ID: 32522433
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
19. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of inductive effects of different concentrations of cyclosporine A on MMP-1, MMP-2, MMP-3, TIMP-1, and TIMP-2 in fetal and adult human gingival fibroblasts.
Nazemisalman B; Sajedinejad N; Darvish S; Vahabi S; Gudarzi H
J Basic Clin Physiol Pharmacol; 2019 Mar; 30(3):. PubMed ID: 30913036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
